Meridian Bioscience Inc.

NASDAQ: VIVO · Real-Time Price · USD
33.97
0.00 (0.00%)
At close: Jan 30, 2023, 10:00 PM

Meridian Bioscience Cash Flow Statement

Financials in USD. Fiscal year is October - September.
Fiscal Year FY 2022 FY 2021
Period Ending Sep 30, 2022 Sep 30, 2021
Net Income
42.46M 71.41M
Depreciation & Amortization
16.51M 15.29M
Stock-Based Compensation
6.9M 4.16M
Other Working Capital
-988K -4.04M
Other Non-Cash Items
7.75M -1.89M
Deferred Income Tax
-1.1M -3.83M
Change in Working Capital
9.84M -18.26M
Operating Cash Flow
82.36M 66.86M
Capital Expenditures
-8.62M -18.31M
Cash Acquisitions
-3.75M -23.59M
Purchase of Investments
n/a n/a
Sales Maturities Of Investments
n/a n/a
Other Investing Acitivies
1.25M 1.5M
Investing Cash Flow
-11.12M -40.4M
Debt Repayment
n/a n/a
Common Stock Repurchased
n/a n/a
Dividend Paid
n/a n/a
Other Financial Acitivies
-34.3M -31.07M
Financial Cash Flow
-34.3M -31.07M
Net Cash Flow
31.68M -3.74M
Free Cash Flow
73.75M 48.55M